Answers are grounded in this paper and cite their sources.
Review highlights high hyponatremia prevalence linked to systemic inflammation in COVID-19 patients, suggesting low sodium may serve as an early indicator of cytokine storm.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as the novel coronavirus disease 2019 (COVID-19), causes an acute respiratory disease that has been reported in nearly all countries globally [1]. The COVID-19 pandemic has infected more than 150 million people around the world, becoming the greatest global public health crisis of all time. Among COVID-19 patients, a significant proportion of cases are hospitalized with pneumonia that can progress to respiratory distress requiring mechanical ventilation, associated with multiple organ failure. Prevalence of hyponatremia in these patients has been reported to be high, between 20% and 35% [2]. The principal cause of COVID-19 death is acute respiratory distress syndrome (ARDS) [3]. A growing body of clinical data suggests that the production of systemic inflammation and the activation of multiple inflammatory pathways are the most important determinants of the ARDS that develops in patients with COVID-19 [4]. In severe cases, systemic inflammation leads to a cytokine storm (CS) [5]. CS not only exacerbates the severity of infection, but also affects various organs and systems (heart, liver, kidney, gastrointestinal system and central nervous system) eventually leading to multiorgan failure [6]. Thus, early recognition and treatment of CS at the appropriate time is of utmost importance in treating critical patients to reduce the mortality rate.
No takes yet. Share an insight, caveat, or question.
Ayus et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: